Literature DB >> 11520772

Regulated control by granulocyte-macrophage colony-stimulating factor AU-rich element during mouse embryogenesis.

L Houzet1, D Morello, P Defrance, P Mercier, G Huez, V Kruys.   

Abstract

In vitro studies have indicated that the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene expression is regulated at the posttranscriptional level by the AU-rich element (ARE) sequence present in its 3' untranslated region (UTR). This study investigated the importance of the ARE in the control of GM-CSF gene expression in vivo. For this purpose, transgenic mice bearing GM-CSF gene constructs containing or lacking the ARE (GM-CSF AU(+) or GM-CSF AU(-), respectively) were generated. Both transgenes were under the transcriptional control of the immediate early promoter of the cytomegalovirus (CMV) to ensure their early, widespread, and constitutive expression. The regulation imposed by the ARE was revealed by comparing transgene expression at day 14 of embryonic development (E14); only the ARE-deleted but not the ARE-containing construct was expressed. Although GM-CSF AU(+) embryos were phenotypically normal, overexpression of GM-CSF in E14 GM-CSF AU(-) embryos led to severe hematopoietic alterations such as abnormal proliferation of granulocytes and macrophages accompanied by an increased number of peroxidase-expressing cells, their putative progenitor cells. These abnormalities compromise development because no viable GM-CSF AU(-) transgenic pups could be obtained. Surprisingly, by E18, significant accumulation of transgene messenger RNA was also observed in GM-CSF AU(+) embryos leading to similar phenotypic abnormalities. Altogether, these observations reveal that GM-CSF ARE is a developmentally controlled regulatory element and highlight the consequences of GM-CSF overexpression on myeloid cell proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520772     DOI: 10.1182/blood.v98.5.1281

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Posttranscriptional silencing of effector cytokine mRNA underlies the anergic phenotype of self-reactive T cells.

Authors:  Alejandro V Villarino; Shoshana D Katzman; Eugenio Gallo; Omer Miller; Shuwei Jiang; Michael T McManus; Abul K Abbas
Journal:  Immunity       Date:  2011-01-13       Impact factor: 31.745

2.  Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family.

Authors:  Deborah J Stumpo; Noah A Byrd; Ruth S Phillips; Sanjukta Ghosh; Robert R Maronpot; Trisha Castranio; Erik N Meyers; Yuji Mishina; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform.

Authors:  Liangxian Cao; Marla Weetall; Jenelle Bombard; Hongyan Qi; Tamil Arasu; William Lennox; Jean Hedrick; Josephine Sheedy; Nicole Risher; Peter C Brooks; Panayiota Trifillis; Christopher Trotta; Young-Choon Moon; John Babiak; Neil G Almstead; Joseph M Colacino; Thomas W Davis; Stuart W Peltz
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

4.  Deletion of AU-rich elements within the Bcl2 3'UTR reduces protein expression and B cell survival in vivo.

Authors:  Manuel D Díaz-Muñoz; Sarah E Bell; Martin Turner
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.